APA (7th ed.) Citation

Annie Mayence & Jean Jacques Vanden Eynde. (2019). Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of <i>Plasmodium vivax</i> Malaria and Prophylaxis of Malaria. MDPI AG.

Chicago Style (17th ed.) Citation

Annie Mayence and Jean Jacques Vanden Eynde. Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of <i>Plasmodium Vivax</i> Malaria and Prophylaxis of Malaria. MDPI AG, 2019.

MLA (9th ed.) Citation

Annie Mayence and Jean Jacques Vanden Eynde. Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of <i>Plasmodium Vivax</i> Malaria and Prophylaxis of Malaria. MDPI AG, 2019.

Warning: These citations may not always be 100% accurate.